{"id":3979,"date":"2019-12-05T16:51:15","date_gmt":"2019-12-05T16:51:15","guid":{"rendered":"https:\/\/www.itelte.it\/our-history\/"},"modified":"2020-02-24T15:43:57","modified_gmt":"2020-02-24T15:43:57","slug":"our-history","status":"publish","type":"page","link":"https:\/\/itelte.it\/en\/our-history\/","title":{"rendered":"Our History"},"content":{"rendered":"

Our history is imbued with the authenticity of our profound values<\/h1><\/div>
<\/div><\/div><\/div>

We are constantly inspired by passion, intellectual curiosity, diversity and inclusion in all our activities. This is our most exciting challenge.<\/p>\n<\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

1982<\/h2><\/div>

Founding of Itel<\/h3><\/div>

Founded in June 1982, Itel begins operating in the fields of telecommunication and radio-relay systems.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

1986<\/h2><\/div>

First MRI shielding<\/h3><\/div>

In Modena, Itel manufactures the first superconductive MRI shielding in Italy, which is donated to the city hospital by Enzo Ferrari.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

1993<\/h2><\/div>

Mobile Units<\/h3><\/div>

MR and Mammography.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

1996<\/h2><\/div>

CE Marking<\/h3><\/div>

Itel\u2019s EMC Test Lab for conformity marking of electric and electronic equipment begins operating<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

1997<\/h2><\/div>

Diamags<\/h3><\/div>

Eur. Pat. EP0899576<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

1997<\/h2><\/div>

OSB Shielding<\/h3><\/div>

Eur. Pat. EP1018860<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2002<\/h2><\/div>

RSNA Meeting<\/h3><\/div>

Chicago<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2007<\/h2><\/div>

Itel develops its presence in the radiopharmaceutical sector<\/h3><\/div>

On July 5, 2007 the construction works for the realization of a new radiopharmaceutical division begin. These finish on August 5, 2009, with AIFA\u2019s approval for radiopharmaceutical production.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

2008<\/h2><\/div>

Founding of Itelpharma<\/h3><\/div>

Itel opens Itelpharma, its radiopharmaceutical division for the production of radiopharmaceuticals for PET diagnostics as well as the provision of products and services for nuclear medicine, radio protection and microbiology.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2009<\/h2><\/div>

Start of the research project on proton therapy<\/h3><\/div>

The new frontier of proton treatment is a linear accelerator, to be implemented in cooperation with INFN and ENEA. The first stage of prototype research and development is established.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2010<\/h2><\/div>

\u201cTurnkey projects\u201d<\/h3><\/div>

Since 2010, Itel has been designing and implementing complex healthcare units and full wards for diagnostic imaging<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2011<\/h2><\/div>

Leonardo Diaferia receives the \u201cCaduceo D\u2019Oro\u201d award<\/h3><\/div>

This prestigious prize is granted annually by the Order of Pharmacists from the two provinces of Bari and BAT, with the support of the Federation of Pharmacists, to individuals who have distinguished themselves within the healthcare sector.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2011<\/h2><\/div>

Inta Operative MR<\/h3><\/div>

—<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2012<\/h2><\/div>

Helium 3 Hyperpolarization<\/h3><\/div>

—<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

2013<\/h2><\/div>

New MR Concept<\/h3><\/div>

—<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2014<\/h2><\/div>

New Mammography Concept<\/h3><\/div>

—<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2014<\/h2><\/div>

\u201cPininfarina\u201d award<\/h3><\/div>

In 2014, Itel is nominated for the prestigious \u201cAndrea Pininfarina\u201d award, dedicated to innovative companies.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2015<\/h2><\/div>

Michele Diaferia appointed as Itel\u2019s CEO<\/h3><\/div>

Since his youth, Michele Diaferia has been employed by the company founded by his father, Leonardo, working with the research team for the implementation of several projects, such as “Massime” (innovative mechatronic safety system for railway, aerospace and robotic applications) and “Amiderha” (minimally invasive advanced systems for diagnostics and radiotherapy).<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2015<\/h2><\/div>

Two-star legality rating<\/h3><\/div>

In August 2015, the Italian Antitrust Authority assigns Itel a two-star legality rating, thus recognizing not only its basic compliance requirements but also other important qualities which outline the ethical aspects of the company.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2015<\/h2><\/div>

Ettore Diaferia takes on the role of Itel\u2019s Board Director<\/h3><\/div>

Ettore Diaferia is responsible for software development and project management<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2016<\/h2><\/div>

Itel joins forces with AAA<\/h3><\/div>

The international company Advanced Accelerator Applications S.A. (\u201cAAA\u201d), specialized in Molecular Nuclear Medicine (MNM) signs an agreement with Itel for the production and distribution of F-18 based radiopharmaceuticals to nuclear medical facilities across southern Italian regions.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2016<\/h2><\/div>

Itel sets up a second production line at Itelpharma, its radiopharmaceutical facility<\/h3><\/div>

2 million euros are allocated for the investment in the facility, which was co-financed by the Region of Puglia as well as through European Community funds.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>

2019<\/h2><\/div>

Founding of Linearbeam<\/h3><\/div>

Linearbeam is a spin-off company from Itel, which devotes its expertise to the development of a complete proton therapy system based on a linear proton accelerator (p-Linac). The financial volume of the investment amounts to \u20ac14.9 million, allocated through the Italian Research and Innovation Fund (RIF) managed by Equiter.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/span><\/div>
<\/div><\/div><\/div>

2019<\/h2><\/div>

The Italian Prime Minister Giuseppe Conte visits Itel<\/h3><\/div>

Following wider interest aroused by EHRA, the linear proton accelerator for cancer treatment, the Italian Prime Minister Giuseppe Conte visits Itel\u2019s and Linearbeam\u2019s premises on April 13, 2019.<\/p>\n<\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div>

Technology for human health<\/span><\/h2>\n<\/div>

Contact us. We will be happy to assist you.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
Contact us<\/span><\/a><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>\n<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2408,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"inline_featured_image":false,"footnotes":""},"_links":{"self":[{"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/pages\/3979"}],"collection":[{"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/comments?post=3979"}],"version-history":[{"count":0,"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/pages\/3979\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/media\/2408"}],"wp:attachment":[{"href":"https:\/\/itelte.it\/en\/wp-json\/wp\/v2\/media?parent=3979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}